Compare GH & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GH | HAS |
|---|---|---|
| Founded | 2011 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 13.2B |
| IPO Year | 2018 | 1994 |
| Metric | GH | HAS |
|---|---|---|
| Price | $82.29 | $93.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 11 |
| Target Price | ★ $119.79 | $109.73 |
| AVG Volume (30 Days) | ★ 2.1M | 1.8M |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | ★ 2.93% |
| EPS Growth | ★ 6.74 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $982,021,000.00 | ★ $5,365,900,000.00 |
| Revenue This Year | $33.30 | $5.38 |
| Revenue Next Year | $28.27 | $6.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 32.88 | 13.06 |
| 52 Week Low | $36.36 | $60.33 |
| 52 Week High | $120.74 | $106.98 |
| Indicator | GH | HAS |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 50.23 |
| Support Level | $82.33 | $92.16 |
| Resistance Level | $92.73 | $94.35 |
| Average True Range (ATR) | 5.10 | 3.11 |
| MACD | -0.20 | 0.24 |
| Stochastic Oscillator | 40.14 | 51.41 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to 19 million digital tabletop players.